A unique partnership between industry and academia has led to human clinical trials of a new drug for a rare class of blood diseases called myeloproliferative disorders, which are all driven by the same genetic mutation and can evolve into leukemia.
Stem Cell Research Leads To Potential New Therapy For Rare Blood...Courtesy ScienceDaily Thu, 04/10/2008 - 01:00
A unique partnership between industry and academia has led to human clinical trials of a new drug for a rare class of blood diseases called myeloproliferative disorders, which are all driven by the same genetic mutation and can evolve into leukemia. More related itemsGene Mutation In Worms Key To Alcohol Tolerance
New Hope For Multiple Sclerosis Sufferers
Potential New Way To Make A Good Anti-leukemia Drug...
Vinegar: Over 400 Various, Versatile, and Very Good...
The Complete Idiot's Guide to Chemistry, 2nd Edition...
|
Popular by tags Week |
Post new comment